NCT07624487: Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 9 Jun 2026
- Primary completion
- 31 Dec 2028
- Arms
- EGFR-TKI with phased chemotherapy
- Results
- None posted
- 3 Jun 2026: Trial registered